Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://alvinwrpi694220.bluxeblog.com/71155144/retaglutide-a-promising-glp-1-receptor-agonist